Compass Group stock price slips into weekend as investors line up Feb 5 update
24 January 2026
1 min read

Compass Group stock price slips into weekend as investors line up Feb 5 update

LONDON, Jan 24, 2026, 08:12 (GMT) — Market closed.

  • Shares of Compass Group dropped on Friday, mirroring the softer close across London stocks that marked the week’s end.
  • Focus shifts to the group’s first-quarter trading update and annual meeting scheduled for Feb. 5.
  • Risk appetite took a hit this week amid geopolitical tensions and fresh tariff reports, leaving traders unsettled.

Compass Group PLC shares dipped 0.7%, ending Friday at 2,239 pence, retreating amid a jittery wider market. 1

London markets stayed closed over the weekend, putting the spotlight on Compass as it prepares to drop its first-quarter trading update on Feb. 5 at 0700 GMT. An analyst call is scheduled for 0900 GMT. This will be the year’s first significant financial report for a stock that’s been acting more like a bond proxy than a growth contender lately. 2

Friday’s session saw the FTSE 100 dip 0.07%, ending its three-week streak as trade and geopolitical worries resurfaced. Investors turned toward safe havens, lifting precious metals and mining shares. Laura Cooper, senior macro strategist at Nuveen, noted, “Gold … remains the preferred portfolio hedge amid ongoing geopolitical risk.” 3

Compass hasn’t been spared in the recent selloff. Its shares have fallen roughly 5.3% this month and slipped about 2.3% over the past week, with investors still waiting on a distinct catalyst beyond typical market fluctuations. 4

That ramps up the pressure on management’s next steps. At the full-year results in November, the company predicted profit growth close to 10% and “organic” revenue growth—stripping out currency effects and acquisitions—of around 7% for 2026. Finance chief Petros Parras told analysts, “We’re seeing inflation slowing down a fraction faster than what we thought last year.” RBC Capital Markets analyst Karl Green called the results “all solid stuff” but noted they probably won’t “excite the average investor.” 5

On Feb. 5, investors will focus on familiar concerns: how much growth stems from price increases versus volume, whether North America remains a strong contributor, and if new contract wins are translating into steady progress in offices, healthcare, and education.

Smaller dates might tweak a steady dividend stock just a bit. Compass lists Feb. 2 as the deadline for currency elections, Feb. 5 for DRIP (dividend reinvestment plan) choices, Feb. 10 for its GBP rate update, and Feb. 26 as the day dividends get paid. 6

The risk is obvious. Should clients push back harder as inflation cools, those pricing gains could vanish quickly, dragging down revenue growth even if demand holds firm. Any sharper hit to business confidence from trade shocks would hit a group that depends heavily on workplace foot traffic and events.

The stock hasn’t broken out yet, sliding this week but holding steady overall. Its moves track the wider market mood more than any fresh company updates.

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
GSK share price in focus after China clears Trelegy for asthma — what to watch next week
Previous Story

GSK share price in focus after China clears Trelegy for asthma — what to watch next week

Why electricity prices are still high in 2026 — and the fight over who pays next
Next Story

Why electricity prices are still high in 2026 — and the fight over who pays next

Go toTop